Anti-VEGF Receptor 2 (phospho Y1054)抗体(ab5472)

发表研究结果有使用 ab5472?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab5472 被引用在 5 文献中.

  • De Luisi A  et al. Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma. Clin Cancer Res 17:1935-46 (2011). WB ; Human . PubMed: 21307145
  • Moschetta M  et al. Bortezomib and zoledronic acid on angiogenic and vasculogenic activities of bone marrow macrophages in patients with multiple myeloma. Eur J Cancer 46:420-9 (2010). WB ; Human . PubMed: 19914061
  • Radek KA  et al. Acute Ethanol Exposure Disrupts VEGF Receptor Cell Signaling in Endothelial Cells. Am J Physiol Heart Circ Physiol : (2008). PubMed: 18469146
  • Coluccia AM  et al. Validation of PDGFR{beta} and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib (BMS-354825/Sprycel(R)). Blood : (2008). PubMed: 18524994
  • Conejo-Garcia JR  et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 10:950-8 (2004). PubMed: 15334073

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"